We determined the treatment modality of hemangioblastoma of the brain stem on the bases of our two cases and 31 cases searching from the literature since 1960 which were treated surgically. Hemangio blastomas of the brain stem were categorized according to one of three locations: hemangioblastoma of the fourth ventricle attached to the floor of the ventricle (Type A), hemangioblastoma of the fourth ven tricle partially embedded in the floor of the ventricle (Type E), and intramedullary hemangioblastoma of the medulla oblongata (Type I); and were evaluated their clinical features including the operative mortality and morbidity of each location. In our two cases of Type I hemangioblastoma, Case 1, re moved partically, died due to sleep apnea and Case 2 lead to normal school life after hemangioblasto mas were removed radically. In our review of the 33 surgically-treated cases, radical excision was car ried out in 29 cases (87.9%). The mortality was 24.2% overall; that of Type A was 25%, Type E was 28.6%, and Type I was 14.3%. In terms of postoperative mortality, the location of the hemangioblasto ma was irrelevant and radical excision was much better than partial removal. Hemangioblastomas of the brain stem could be removed radically by meticulous dissection of the tumor on distinct cleavage, even in cases of intramedullary location. Microsurgical dissection of medullary hemangioblastomas with low morbidity is feasible and prudent postoperative care is mandatory to reduce the operative mor tality and morbidity.
Tl-weighted MR imaging revealed a large isoin tense mass lesion in the dorsal medulla, associated with a caudal low intensity area and displacing the vermis superiorly and both tonsils posterolaterally (Fig. 2 ). T2-weighted MR imaging revealed a cord like flow void sign in the hyperintense mass lesion, and except for the cystic component at the caudal posterior arch were performed in October 1994. Af ter opening the dura, dilated red veins were located on the dorsal medulla, the inferior vermis was dis placed upwardly, and both tonsils were displaced dorsolaterally.
The caudal floor of the fourth ventri cle had protruded, and a cherry red, vascular-rich mass was seen through the thin dorsal medulla, sug gesting an intramedullary mass (Fig. 3) . Under the operating microscope, a midline incision was made in the dorsal medulla, and the tumor was dissected from the brain stem. There was a delicate gliotic cleavage between the tumor and the surrounding brain tissue. The tumor was gently rolled back, forth to coagulate, and separate the feeding arteries. The tumor shrank and was removed totally en bloc. Venous oozing from the tumor bed was controlled by oxycel and cottonoid packing. 
Review of the Literature
We reviewed 33 surgically-treated cases of heman gioblastoma of the brain stem, 31 collected from the literature available to us and the two cases described above (Table 1A -C). 1-3'6,8-10,12,14-16,18,23,26-31) We catego rized them by tumor location: 12 cases (36.4%) of hemangioblastoma of the fourth ventricle attached to the floor of the ventricle (Type A), 14 cases (42.4%) of hemangioblastoma partially embedded in the floor of the ventricle (Type E), and seven cases (21.2%) of intramedullary hemangioblastoma of the medulla oblongata (Type I). Cases of hemangioblasto ma of the fourth ventricle were more frequent than cases of intramedullary hemangioblastoma:
79% of the total cases involved the fourth ventricle. These tumors were most frequently located in the dorsal medulla oblongata, especially in the area postre ma.2'9'14,29) Hemangioblastoma appeared at varying patient ages, from 15 years to 68 years; average age was 33 years, with the greatest frequency in the 3rd and 4th decades. In 55% of the cases the patients were males.
The frequency of symptoms stemming from in tracranial hypertension (headache, nausea, and vomiting) were 83%, 50%, and 86% for Type A, E, and I hemangioblastomas, respectively. Eighty-three percent of the patients with Type A hemangioblasto ma had unsteady gait, and 33% had numbness of the extremities. Thirty-six percent of the patients with Type E hemangioblastoma had ataxia, and 29% had diplopia. In the patients with Type I hemangioblasto ma, 86% showed ataxic gait and/or incoordination, and 43% had dysphagia and/or dysarthria. All these symptoms were more frequent in the Type I group than in the others. The mean durations of the preoperative symptoms for the Type A, E, and I groups were 8.8, 20.5, and 9 months, respectively.
In neurological examinations, cerebellar signs were present most frequently, followed by papillede ma in 42%, 29%, and 50% in Type A, E, and I cases, respectively. Bulbar signs appeared most often in Type I (67%). The tumor was solid in 87% of all cases reviewed and was associated with small cysts or peritumoral cysts in 10 of 27 cases (37%). Tumor size exceeded 25 mm in diameter in seven of nine Type A cases. Of the 14 Type E cases, the tumor was smaller than 25 mm in diameter in all but two cases. In three of the four Type I cases, the tumor was rather large, exceeding 30 mm. Cystic hemangio blastoma has been reported in only four cases, 2,8,15,23) and the mural nodules in these cases were between 6 and 20 mm in diameter. In terms of surgical procedures, radical excision was carried out in 29 cases (87.9%), partial removal in three cases, and cyst drainage in one case. Partial removal was done in two cases of Type E and in one case of Type I hemangioblastoma. Surgical mortality was found in 24.2% of all the cases under review; in 25% of the Type A group, 28.6% of the Type E group, and 14.3% of the Type I group. In two of the three cases involving partial removal of the tumor, the patients died soon after surgery. In the Type A group (Table 1A) , the tumor was radically excised in 12 cases; three patients died postoperatively, and one died 1 year and 2 months later due to tumor me tastasis in the basal ganglia. In the Type E group (Table 1B) , the tumor was radically excised in 11 cases; four patients died postoperatively due to bul bar palsy and unstable vital signs. Among the mor talities, the tumor had been radically excised in three patients and partially excised in the fourth. One patient underwent cyst drainage and had an un eventful recovery after surgery. Of the seven Type I cases (Table 1C) , the tumor was radically excised in six patients, and four of them were able to resume normal life. In the one case in which the tumor was partially excised, the patient died postoperatively due to a sleep apnea attack.
Discussion
Hemangioblastoma of the brain stem is rare, with only 33 cases, including our cases, surgically treated since 1960 (Table 1) . [1] [2] [3] 6, [8] [9] [10] 12, [14] [15] [16] 18, 23, [26] [27] [28] [29] [30] [31] Anatomical ly, the dorsal medulla oblongata and the fourth ven tricle are the most frequent sites .2') The dorsal medul la oblongata is very important because of the critical respiratory, vasomotor, and vagal centers.') Heman gioblastoma of the fourth ventricle originates from a vascular mesenchymal plate in or adjacent to the posterior end of the floor of the ventricle (posterior medullary velum), which develops in the 3rd month of fetal life.2,24) Therefore, this caudal floor of the fourth ventricle, i.e., posterior medullary velum, is another common site. Clinically and surgically, hemangioblastoma of the brain stem is a highly vas cular tumor, and was solid in 26 of 30 cases (Table 2) . Cystic hemangioblastoma of the brain stem is rare compared with the high frequency in cerebellar hemangioblastoma (64.7-74%),11,19,24) with only four cases reported .1,1,11,13) The blood supply to the tumor originates from the posterior inferior cerebellar ar tery, which lies deep in the tumor, and dilated red veins are located dorsally. The tumor is often not easy to excise completely without causing neurologi cal deficit, due to the hypervascularization of the tumor and its critical location with respect to blood supply and draining. Patients often suffer from low er cranial nerve involvement and damage to their respiratory and circulatory centers. Table 2) . The overall mortality in the 33 surgically-treated cases was 24.2% (8/33 cases). The postoperative mor tality was not significantly different at any location, although the mortality of cases located in the fourth ventricle was somewhat higher than in intramedulla ry cases ( Preoperative irradiation may decrease the opera tive risk. 1,11,17'22) Preoperative irradiation with 6000 rads reduced a tumor by about 45% after 44 months.") Gamma knife radiosurgery of 11 cases of soli tary small or medium-sized hemangioblastoma caused shrinkage or stopped growth with a marginal dose of 10 to 15 Gy, but the adjoining cyst did not respond and required later evacuation. 17) Treatment of a hemangioblastoma of the fourth ventricle by radiosurgery resulted in no change in tumor size in 2 years of follow up.5) Further investigation of the ef fect of radiosurgery is needed. 
